Arbor Pharmaceuticals

November 02, 2020

US FDA approval tracker: October

October 30, 2020

Go or no go? Big decisions loom for Bristol and Sanofi

The FDA will have a busy November, with decisions due for Bristol, Sanofi and Y-mabs, among others.

October 02, 2020

Go or no go? Vaccine panel upstages US approval decisions

October brings US approval decisions for Eysuvis and Brilinta, while a panel meeting sets up a discussion around Covid-19 vaccines.

May 25, 2016

Albireo finds a way to go public

May 24, 2016

Xenoport goes out with a whimper